Nasdaq:US$40.98 (-0.83) | HKEX:HK$71.80 (-5.80) | AIM:£5.92 (+0.14)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 2 Jul 2007

Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis

1 items
a070702